29 June 2023
2022 Annual Review
In five years, our agreements have enabled 530 million people in over 95 countries to access medical innovations. During this time, we have announced 10 agreements to increase access to health products that tackle COVID-19, HIV, malaria, tuberculosis and syphilis. And to date, price reductions negotiated as part of our agreements have saved more than $91 million for governments and procurers.
Read our 2022 Annual Review to find out how we used innovative finance to increase access to health products.